H-LNILNNNYK^-OH
Ref. 3D-PP45885
| Undefined size | To inquire |
Product Information
- NH2-Leu-Asn-Ile-Leu-Asn-Asn-Asn-Tyr-Lys^-OH
Peptide H-LNILNNNYK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LNILNNNYK^-OH include the following: Multiple and selective reaction monitoring using triple quadrupole mass spectrometer: preclinical large cohort analysis Q Fu, Z Chen, S Zhang , SJ Parker , Z Fu, A Tin - Proteomics by Mass , 2016 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-3524-6_15 Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury M Andrews, T Yoshida , CM Henderson, H Pflaum - PloS one, 2022 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0276649 Most ApoL1 is secreted by the liver K Shukha, JL Mueller , RT Chung - Journal of the , 2017 - journals.lww.comhttps://journals.lww.com/jasn/fulltext/2017/04000/most_apol1_is_secreted_by_the_liver.13.aspx Plasma levels of risk-variant APOL1 do not associate with renal disease in a population-based cohort J Kozlitina , H Zhou, PN Brown, RJ Rohm - Journal of the , 2016 - journals.lww.comhttps://journals.lww.com/jasn/fulltext/2016/10000/Plasma_Levels_of_Risk_Variant_APOL1_Do_Not.30.aspx High-throughput screening to identify small molecules that selectively inhibit APOL1 protein level in podocytes J Choy, Y Kan, S Cifelli, J Johnson - the Science of Drug , 2021 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/24725552211026245
Chemical properties
Technical inquiry about: 3D-PP45885 H-LNILNNNYK^-OH
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
